Pyxis Announces Pricing of Upsized Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
IPO for Pyxis Oncology (PYXS) Upsized IPO Opens 19% Higher, Valuing Co. at ~$580M
October 8, 2021 11:06 AM EDTToday's IPO for Pyxis Oncology, Inc. (Nasdaq: PYXS) opened for trading at $19 after pricing 10,500,000 shares of common stock at an initial public offering price of $16.00 per share, the high end of the range. The IPO size was raised from 9,500,000 shares and prior to that from 8,340,000... More
